(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.36%) $0.927
(0.79%) $10.85
(0.14%) $0.792
(0.13%) $92.56
Live Chart Being Loaded With Signals
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology...
Stats | |
---|---|
Today's Volume | 58 648.00 |
Average Volume | 64 894.00 |
Market Cap | 2.50B |
EPS | CHF0 ( 2024-02-16 ) |
Next earnings date | ( CHF0 ) 2024-04-18 |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | -12.08 |
ATR14 | CHF0.0870 (0.19%) |
Volume Correlation
BB Biotech AG Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BB Biotech AG Correlation - Currency/Commodity
BB Biotech AG Financials
Annual | 2023 |
Revenue: | CHF-199.57M |
Gross Profit: | CHF-199.57M (100.00 %) |
EPS: | CHF0 |
Q4 | 2023 |
Revenue: | CHF111.17M |
Gross Profit: | CHF111.17M (100.00 %) |
EPS: | CHF0 |
Q3 | 2023 |
Revenue: | CHF-40.70M |
Gross Profit: | CHF-40.70M (100.00 %) |
EPS: | CHF-0.890 |
Q2 | 2023 |
Revenue: | CHF-4.68M |
Gross Profit: | CHF-4.68M (100.00 %) |
EPS: | CHF-0.240 |
Financial Reports:
No articles found.
BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators